Abbreviations {#nomen0010}
=============

NAc

:   nucleus accumbens

PL

:   prelimbic cortex

IL

:   infralimbic cortex

mPFC

:   medial prefrontal cortex

OFC

:   orbitofrontal cortex

DLS

:   dorsolateral striatum (caudate putamen)

Amyg

:   amygdala

6-OHDA

:   6-hydroxydopamine

5,7-DHT

:   5,7-dihydroxytryptamine

MDMA

:   3,4-methylenedioxymethamphetamine

DA

:   dopamine

NA

:   noradrenalin

5-HT

:   serotonin

DOPAC

:   3,4-dihydroxyphenylacetic acid

5-HIAA

:   5-hydroxyindoleacetic acid

HVA

:   homovanillic acid

HPLC-ECD

:   high performance liquid chromatography with electrochemical detection

Specifications TableSubjectNeuroscienceSpecific subject areaRegional differences in rat brain monoaminergic functionType of dataTable (data origins)\
Figures (averaged data from preliminary analyses in SPSS)\
Excel (raw Dataset 1 in Supplementary Material 1)\
SPSS (raw Dataset 2 in Supplementary Material 2)How data were acquiredHigh performance liquid chromatography with electrochemical detection using a glassy carbon electrode flow cell (VT-03 Antec) with an ISAAC reference electrode. Samples were subsequently analysed using the Alexys software data system.Data formatRaw\
AnalysedParameters for data collectionThe data are compiled from control (untreated) brain samples taken during a series of experimental *in vivo* studies. Tissue samples were taken only from a limited number of brain regions of *a priori* interest.Description of data collectionThese studies followed a standard methodology for tissue sampling and HPLC-ECD. In each case, the rats were humanely killed by dislocation of the neck and decapitated; the brains were removed rapidly and dissected on a cold tray.\
Tissue samples were then taken using a micro-punch procedure from 2 mm coronal brain sections. Brain regions were identified using *The Rat Brain in Stereotaxic Coordinates* \[[@bib1]\], using 0.84 and 1.6mm punches (depending on the size of the region to be sampled).Data source locationNottingham\
UKData accessibilityThe data are hosted with the article.**Value of the Data**•The dataset contributes a large sample of baseline data (up to *N* = 112) to compare with other assays of neurotransmitters and their metabolites in selected brain regions, including data by cerebral hemisphere (laterality) where available.•Neuroscientists, neuropharmacologists and statisticians can benefit from this dataset, which allows investigation of intercorrelations between monoaminergic parameters in cortical and sub-cortical structures.•The dataset allows interrogation, both for exploratory approaches and to test specific hypotheses as to how functional interconnectivity ([Fig. 1](#fig1){ref-type="fig"}) is reflected in neurotransmitter function.Fig. 1Medial prefrontal cortex (mPFC) and nucleus accumbens (NAc) interconnectivity. Local inhibitory interactions between prelimbic (PL) and infralimbic (IL) areas of mPFC and between core and shell sub-regions of NAc are denoted by **-**.Fig. 1•The dataset can be used to provide further insights into other functional interrelationships between neurotransmitter systems in the regions examined.•This dataset can be used to inform the development of future experiments to examine functional interconnectivity, in particular disconnection studies in the case of differences by cerebral laterality.•The additional value of the pooled dataset provided in the present resource is the derived from the sample size and provision of data by cerebral laterality (where available).

1. Data {#sec1}
-------

The dataset provided with this article contains raw HPLC-ECD measures in two formats (Dataset 1 in Supplementary Material 1; Dataset 2 in Supplementary Material 2), together with some summary data ([Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}). The dataset was compiled from control (untreated) brain samples taken during a series of experimental *in vivo* studies ([Table 1](#tbl1){ref-type="table"}). Tissue samples were taken only from a limited number of brain regions of *a priori* interest.Fig. 2Summary data from analysis in SPSS of the raw data provided in Dataset 2. Mean levels of (A) dopamine (DA) *N* = 92, (B) noradrenalin *N* = 56 and (C) serotonin (5-HT) *N* = 92 expressed as pmoles per μg of protein content for core and shell nucleus accumbens (NAc) and prelimbic (PL) and infralimbic (IL) medial prefrontal cortex (mPFC).Fig. 2Fig. 3Summary data from analysis in SPSS of the raw data provided in Dataset 2. Mean levels of (A) dopamine (DA) *N* = 98, (B) noradrenalin *N* = 62 and (C) serotonin (5-HT) *N* = 98 expressed as pmoles per μg of protein content for core and shell nucleus accumbens (NAc) by left and right hemisphere.Fig. 3Table 1Data origins by brain regions available and publication reference.Table 1Studies pooledControl sample *N*Brain regions availablePublication referenceNAc\
6-OHDA 1&236NAc core vs shellDLSPL, ILJournal of Psychopharmacology, 25, 1649--1660 \[[@bib5]\]NAc\
6-OHDA 323NAc core vs shellDLSPL, ILPharmacology, Biochemistry and Behavior, 98, 1--7 \[[@bib4]\]PL/IL 6-OHDA 120NAc core vs shellDLSPL, IL, OFCAmygNeuroscience, 170, 99--106 \[[@bib3]\]NAc 5,7-DHT 121NAc core vs shellDLSPL, ILAmygInternational Journal of Neuropsychopharmacology, 15, 485--496 \[[@bib6]\]MDMA -- systemic12NAcmPFCAmygNeuropharmacology, 67, 331--336 \[[@bib7]\]

This dataset can be used for exploratory approaches and to test specific hypotheses as to how functional interconnectivity is reflected in neurotransmitter function \[[@bib2]\]. The dataset can further be used to identify laterality differences in neurotransmitter function. These are of interest in their own right and can in principle be taken into account in statistical models of functional interconnectivity mediated by the monoamines. When samples are taken to verify the effectiveness of an experimental intervention such as the injection of a neurotoxin, the convention is to pool the samples from the right and left hemispheres prior to analysis and this is the approach that we have previously adopted, to assess the effects of dopaminergic depletion using 6-OHDA \[[@bib3], [@bib4], [@bib5]\], serotonergic depletion using 5,7-DHT \[[@bib6]\], and systemic MDMA \[[@bib7]\].

[Table 1](#tbl1){ref-type="table"} shows how the present dataset derives from the previously published studies (labelled by the intervention in use in the experimental group and any applicable replication number), together with the maximum sample sizes and brain regions available.

### 1.1. Data organisation {#sec1.1}

The same data are provided in Excel and SPSS format. In addition to the information provided in [Table 1](#tbl1){ref-type="table"}, the Excel file also provides the rats\' behavioural group allocation in the raw data sheet (column 4). As allocation to behavioural group conditions is balanced for each of the control groups, this variable is unlikely to show much systematic effect. We have nonetheless included it for completeness (the abbreviations used to denote the behavioural groups can be clarified by the further details provided in the corresponding publication reference). The summary sheet otherwise duplicates the information provided in [Table 1](#tbl1){ref-type="table"}.

The SPSS file includes the original rat id and an abbreviated form of the [Table 1](#tbl1){ref-type="table"} study descriptor based on the experimental intervention (labelled cohort). The data labels in the subsequent columns refer to the brain region and neurotransmitter/metabolite sampled using the standard abbreviations defined above.

2. Experimental design, materials, and methods {#sec2}
----------------------------------------------

These are fully described in the earlier published papers \[[@bib3], [@bib4], [@bib5], [@bib6], [@bib7]\]. All procedures conducted prior to the post mortem tissue sampling and assays were carried out in accordance with the United Kingdom (UK) Animals Scientific Procedures Act 1986, Project Licence number: PPL 40/3163.

These previous studies followed a standard methodology for tissue sampling and HPLC-ECD. In each case, the rats were humanely killed by dislocation of the neck and decapitated; the brains were removed rapidly and dissected on a cold tray. Tissue samples were then taken using a micro-punch procedure. Using ice-chilled razor blades, three 2 mm coronal brain sections were cut. The posterior side of the slices corresponded to approximately +3, +1 and −3 mm from bregma. Subsequently, the three 2 mm coronal sections were placed posterior side up onto an ice-chilled plate. The brain regions were identified using *The Rat Brain in Stereotaxic Coordinates* \[[@bib1]\] and sampled from the appropriate section, using 0.84 and 1.6mm punches (depending on the size of the region to be sampled). The brain samples were then immediately frozen on dry ice and stored at −80 °C until assay by HPLC-ECD to determine neurotransmitter and metabolite levels.

The data from some regions are pooled across the right and left hemispheres because the hemispheres were not separately sampled. For example, the PL and IL sub-regions of mPFC are medial to the midline and separate punches would have resulted in samples too small for assay by HPLC-ECD. Similarly (where sampled) OFC tissue was also pooled across right and left \[[@bib3]\]. The core NAc, shell NAc, DLS and Amyg were punched by hemisphere and all the available data for these regions provided by right/left hemisphere. Thus the effect of laterality can be investigated for these regions (*N* = 100 for NAc and DLS, *N* = 53 for Amyg). However, there was no differentiation of NAc sub-regions in the study of the effects of systemic MDMA in which a larger punch was used \[[@bib7]\]. Caudate putamen \[[@bib3],[@bib5],[@bib6]\] and DLS \[[@bib4]\] refer to the same sample (the same punch was used to extract the anatomically equivalent sample) and these samples are all labelled DLS in the dataset.

Just prior to HPLC-ECD, the tissue samples were homogenised in 0.1 M PCA solution by sonication and centrifuged at 17400 g for 20 min at 4 °C before amine and metabolite levels were detected using a glassy carbon electrode flow cell (VT-03 Antec) with an ISAAC reference electrode. An external standard consisting of 5-HT, DA, and metabolites, in concentrations of 10^−7^, 0.5 × 10^−7^ and 10^−8^ M was injected at a volume of 4 μl for calibration. Samples were injected onto the column at 4 μl volumes, except for PL, IL, OFC and Amyg samples which were injected at 8 μl because of the higher detection thresholds in these regions. Samples were subsequently analysed using the Alexys software data system. The Bradford assay was routinely used to adjust for protein content (using the pellet remaining after sample centrifugation).

### 2.1. Preliminary statistical analyses {#sec2.1}

Summary data for selected regions of interest are shown in [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}. [Fig. 2](#fig2){ref-type="fig"} shows how levels of DA, NA and 5-HT vary across interconnected regions of NAc and mPFC. [Fig. 3](#fig3){ref-type="fig"} shows levels of DA, NA and 5-HT by laterality for core and shell NAc. Some variation in the available sample sizes reflects missing data in the original studies.
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